Péptidos antihipertensivos derivados de proteínas lácteas

La leche es una excelente fuente de nutrientes. Mas allá de su bien documentada función nutricional, la leche ejerce un amplio rango de actividades biológicas que influyen sobre el sistema digestivo y metabólico, el crecimiento y desarrollo de los órganos y la resistencia a diversos trastornos y enfermedades. Estas actividades han sido atribuidas principalmente a las proteínas y péptidos secretados en la leche por la glándula mamaria. Sin embargo, algunas de las actividades biológicas de las proteínas lácteas se encuentran en un estado latente y requieren de procesos de proteolisis para su liberación.Este trabajo ha sido realizado en el marco del Proyecto CYTED XI.24. También se agradece a los Proyectos Consolider 2010 CS-063 y CM-S0505 -AGR-0153 y AGL- 2007 065035. Blanca Hernández-Ledesma disfruta de un contrato post-doctoral Marie-Curie de la Comisión Europea coordinado por el Consejo Superior de Investigaciones Científicas. María del Mar Contreras disfruta de una beca DANONE.Peer Reviewe

Microencapsulation of a whey protein hydrolysate within micro-hydrogels: Impact on gastrointestinal stability and potential for functional yoghurt development

Gelatin and chitosan micro-hydrogels containing a potentially bioactive whey protein hydrolysate were developed through spray drying and the impact of microencapsulation on protection during digestion and peptide stability against lactic acid fermentation during yoghurt manufacturing was assessed. The results showed that the protection exerted by the encapsulation structures during milk fermentation was sequence- and matrix-dependent, being chitosan more effective than gelatin in stabilising the peptides. However, only 5 out of the 21 fermentation-susceptible peptides identified could be protected through encapsulation within chitosan (1 of which was also protected by gelatin). Moreover, the encapsulation within chitosan microparticles did not substantially affect the peptide profile of the digested hydrolysate, and therefore, the peptide bioaccessibility was not expected to be compromised.Laura G. Gómez-Mascaraque is the recipient of a predoctoral contract from the Spanish Ministry of Economy and Competitiveness (MINECO), Call 2013. The authors would like to thank the Spanish MINECO projects AGL2015-63855-C2-1 and AGL2015-66886-R for financial support.Peer reviewe

Dairy Debaryomyces hansenii strains produce the antihypertensive casein-derived peptides LHLPLP and HLPLP

The ability of dairy Debaryomyces hansenii, Kluyveromyces lactis and Kluyveromyces marxianus strains to release the casein-derived antihypertensive sequences RYLGY, AYFYPEL, LHLPLP, HLPLP, VPP and/or IPP was examined. Yeast strains were grown in medium with casein as sole nitrogen source and the yeast casein hydrolysates (CSHs) were analysed by HPLC-MS/MS to search for the six antihypertensive sequences. Only LHLPLP and HLPLP were identified in CSHs and exclusively in D. hansenii Dh1 and Dh14 hydrolysates in which both antihypertensive sequences represented approximately 6 (CSH Dh1) and 10% (CSH Dh14) of total peptide content. In addition, a complete analysis of selected CSHs by HPLC-MS/MS allowed the identification of 35 (Dh1) and 46 (Dh14) additional peptides, which could also contribute to the observed in vitro ACE inhibitory potency of both hydrolysates (Dh1, IC50 = 13.6 ± 1.8 μg/mL; Dh14, IC50 = 17.5 ± 2.1 μg/mL) and might confer them multifunctional properties. Finally casein zymography revealed the presence of at least one extracellular protease with a molecular mass of about 50 kDa. In conclusion, the present study contributes to a better insight into bioactive compounds produced by dairy yeasts and shows the feasibility of D. hansenii strains to produce antihypertensive casein-derived peptides.This work was supported by grants AGL2010-21009 and AGL2011-24643 from ‘Ministerio de Educación y Ciencia – FEDER’, Consolider Ingenio 2010, Fun-C-Food, CSD2007-00063 and RETICS INVICTUS RD12/0014/0004 from ‘Instituto de Salud Carlos III’. A. García-Tejedor and L. Sánchez-Rivera are recipients of predoctoral fellowships from ‘Ministerio de Educación y Ciencia’ (BES-2011-044424) and CSIC (JAE-PreDoc), respectively.Peer reviewe

Effects of milk casein hydrolyzate supplemented with phytosterols on hypertension and lipid profile in hypercholesterolemic hypertensive rats

This study investigates the beneficial effect of a milk casein hydrolyzate supplemented with phytosterols in hypercholesterolemic hypertensive rats. Spontaneously hypertensive rats were fed for 8 weeks with standard diet, or high cholesterol diet alone and supplemented with casein hydrolyzate or casein hydrolyzate plus phytosterols. Blood pressure was measured by tail-cuff method, vascular reactivity was performed on isolated aorta and biochemical parameters were evaluated in plasma. The hypercholesterolemic diet caused elevation of total cholesterol, low-density lipoprotein cholesterol, atherogenic index, lipid peroxidation, liver size and hepatic steatosis accompanied with a severe reduction of high-density lipoprotein cholesterol. The treatment with the casein hydrolyzate reduced blood pressure, cardiac hypertrophy and oxidative stress, and improved the endothelial function. The incorporation of phytosterols prevented the changes caused by the hypercholesterolemic diet and increased the antioxidant effect of casein hydrolyzate. In conclusion, treatment with milk casein hydrolyzate supplemented with phytosterols provides benefits when coexisting hypertension and hypercholesterolemia.This work was supported by project FP7-SME-2012-315349 (FOFIND) financed by the European Commission. Pedro Ferreira Santos was the recipient of a fellowship funded from this project.Peer Reviewe

Selective isolation of cationic amino acids and peptides by electro-membrane filtration

International audienceIn the food industry there is a clear trend towards the production of speciality products with a high added value. Electro-membrane filtration (EMF) can be used to separate and concentrate these products from complex solutions. With EMF, lysine was separated from a model solution and a protein hydrolysate both containing leucine. The lysine fraction in the permeate ranged from 0.86 to 0.96. The lysine transport rate and purity were improved by increasing the potential difference from 20 V to 40 V. Reduction of the transmembrane pressure from 2 to 0.5 bar improved the purity at a practically unchanged lysine transport rate. An enriched fraction of antibacterial cationic peptides (e.g. lactoferricin-B) could be produced from a lactoferrin hydrolysate using EMF. Isolation of these bioactive peptides is normally expensive due to the complex nature of the hydrolysate feed. EMF has the potential to become an attractive (partial) isolation technology

Protein Profile and Simulated Digestive Behavior of Breast Milk from Overweight and Normal Weight Mothers

Human milk proteins have shown to vary in concentration and distribution through lactation. However, while some regulatory components, such as hormones, have shown associations with regard to the mothers’ body mass index, there is limited information on the possible influence of this condition on the whole protein distribution. The objective of this study was to evaluate the protein profile of human milk from normal weight and overweight or obese mothers to identify differences in protein expression in colostrum, transitional and mature milk. The mass spectrometry analysis showed the ability to class with a high degree of confidence the lactation state and the milk profile according to the mother’s condition. Individual milk samples were subjected to a digestion in vitro model that takes into account the specificities of the gastrointestinal conditions of full-term newborn infants. The digestion products were compared with available data from the digestive contents in newborns. The behavior of the most abundant proteins and the overall peptide generation and survival, showed good correspondence with in vivo data.PID2019-107663RB-I00 from Ministry of Science and Innovation (MICINN)FPU grant (FPU15-04549) from the Spanish Ministry of Education, Culture and Sport

Novel Antihypertensive Lactoferrin-Derived Peptides Produced by Kluyveromyces marxianus: Gastrointestinal Stability Profile and In Vivo Angiotensin I-Converting Enzyme (ACE) Inhibition

Novel antihypertensive peptides released by Kluyveromyces marxianus from bovine lactoferrin (LF) have been identified. K. marxianus LF permeate was fractionated by semipreparative high performance liquid chromatography and 35 peptides contained in the angiotensin I-converting enzyme (ACE)-inhibitory fractions were identified by using an ion trap mass spectrometer. On the basis of peptide abundance and common structural features, six peptides were chemically synthesized. Four of them (DPYKLRP, PYKLRP, YKLRP, and GILRP) exerted in vitro inhibitory effects on ACE activity and effectively decreased systolic blood pressure after oral administration to spontaneously hypertensive rats (SHRs). Stability against gastrointestinal enzymes suggested that the sequence LRP could contribute to the in vivo effects of parental peptides. Finally, there were reductions in circulating ACE activity and angiotensin II level in SHRs after either DPYKLRP or LRP intake, thus confirming ACE inhibition as the in vivo mechanism for their antihypertensive effect.This work was supported by grant AGL2010–21009 from ‘Ministerio de Educación y Ciencia - FEDER’, Consolider Ingenio 2010, Fun-C-Food, CSD2007–00063 and RETICS INVICTUS RD12/0014/0004 from ‘Instituto de Salud Carlos III’. A.G.-T. is the recipient of a predoctoral fellowship from ‘Ministerio de Educación y Ciencia’ (BES-2011–044424).Peer reviewe

Quantitative determination of active Bowman-Birk isoinhibitors, IBB1 and IBBD2, in commercial soymilks

Naturally-occurring serine protease inhibitors of the Bowman-Birk family exert their potential chemopreventive and/or therapeutic properties via protease inhibition. In this study, we have quantified the amounts of active BBI isoinhibitors, IBB1 and IBBD2, in six commercial soymilks. By using cation exchange chromatography, the BBI isoinhibitors were isolated and their specific trypsin inhibitory activity was used to estimate their amounts in soymilk samples. IBB1 and IBBD2 concentrations ranged from 0.44 to 5.20 and 0.27 to 4.60 mg/100 ml of soymilk, respectively; total BBI, considered as the sum of both isoinhibitors, ranged from 0.60 to 9.07 mg/100 ml of soymilk. These data show that physiologically relevant amounts of active BBI are present in commercial soymilk and may exert potential health-promoting effects.A.C. acknowledges support by ERDF-co-financed Grant from the Spanish CICYT (AGL2011-26353). A.C. is involved in COST Action FA1005 INFOGEST on Food Digestion. L.C.B.R. acknowledges support from CAPES (Programa Institucional de Doutorado Sanduíche no Exterior–PDSE process number 9004-11-4), Brazil. We are grateful to the proteomics Facility of University of Cordoba (Spain) for carrying out peptide mass fingerprinting. B.H.-L. thanks Ministry of Economy and Competitiveness for her “Ramón y Cajal” contract.Peer Reviewe

Stability to technological processes of antihypertensive peptides

Trabajo presentado al "EFFoST Annual Meeting: Food Health & Safety" celebrado en Dublin (Irlanda) del 10 al 12 de noviembre de 2010.AGL2007-65035; AGL2008-01713; CENIT-DEV-MET-FUN; CONSOLIDER INGENIO 2010 FUN-C-FOOD CSD 2007-063; P2009/AGR-1469. M. M. Contreras was the recipient of a fellowship of Danone Institute.Peer reviewe

Use of a casein-derived peptide and compositions thereof as antihypertensive

Use of a casein-derived peptide with antioxidant and ACE-inhibitory activity in vitro and antihypertensive activity in mammals, and compositions thereof. This peptide may be use as active ingredient in pharmaceutical, cosmetic and/or dermatological compositions, dietary supplements or as food ingredient. Also relates with composition comprising this peptide in specific concentrations, and fermented compositions, including fermented dairy product, that have enhanced stability under various storage conditions, and their uses.Peer reviewedConsejo Superior de Investigaciones Científicas (España), Universidad de SalamancaA1 Solicitud de patente con informe sobre el estado de la técnic